Scarica l'app Stockscreener
0.7368
4.31%
-0.0332
Dopo l'orario di chiusura:
.72
-0.0168
-2.28%
Celularity Inc Borsa (CELU) Ultime notizie
Celularity Inc. Warrant (CELUW) Holds at $0.01 Amid Minimal Volatility – Key Levels in FocusPCR Moving Average - newsline.com
Celularity Inc. 8-K Filing June 2026: Nasdaq Listing, Company Details, and Securities Information - Minichart
Celularity Faces Nasdaq Listing Compliance Risk After Notice - TipRanks
Celularity receives Nasdaq notice for non-compliance with $35 million market value rule - Investing.com
Celularity Received Notice of Noncompliance - TradingView
[8-K] Celularity Inc Reports Material Event - Stock Titan
Celularity (CELU) Slips 6% as Stock Approaches Key Support at $0.69Price Gap Fill - newsline.com
Celularity Inc. (CELU) Slips 7.4% as Selling Pressure Continues Near Key SupportLow Volatility Picks - newsline.com
CELU - Finviz
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies - The Manila Times
New Florida law lets doctors use placental cell therapy before FDA approval - Stock Titan
Celularity names Rick Gonzalez as chief commercial officer - Investing.com UK
Celularity: Actions Are Intended to Streamline Business and Concentrate Resources >CELU - Moomoo
Celularity refocuses on cell therapy after biomaterials sale - Investing.com
Celularity Appoints Rick Gonzalez as Chief Commercial Officer - TipRanks
Celularity names Rick Gonzalez as Chief Commercial Officer - TradingView
New Celularity (NASDAQ: CELU) CCO to drive cenplacel-L and Lifebank growth - Stock Titan
Celularity refocuses on cell therapy after biomaterials sale By Investing.com - Investing.com UK
Celularity Releases CEO Letter to Shareholders - The Manila Times
Celularity outlines placenta cell therapy push to extend health span - Stock Titan
Celularity Inc. Appoints Rick Gonzalez as Chief Commercial Officer - geneonline.com
Celularity names Rick Gonzalez as chief commercial officer By Investing.com - Investing.com Australia
Celularity: Taken Important Steps to Sharpen Strategic Focus, Strengthen Fincl Position and Enable Celularity to Pursue the Opportunities Most Closely Aligned With Founding Vision - Moomoo
Celularity Inc. Appoints Rick Gonzalez as Chief Commercial Officer, Effective May 29, 2026 - marketscreener.com
Celularity Receives Nasdaq Notice Regarding Form 10-Q - marketscreener.com
Celularity face Nasdaq listing rule breach after missing Q1 10-Q SEC filing - MSN
Celularity gets Nasdaq notice for delayed Q1 2026 Form 10-Q filing, must submit compliance plan by July 28. - Pluang
Celularity Inc. Notified of Non-Compliance with Nasdaq Listing Rule Due to Delayed 10-Q Filing - Quiver Quantitative
Nasdaq flags Celularity for missing Q1 2026 10-Q filing - Stock Titan
Celularity Enters Settlement, Restructuring Financing Obligations - TipRanks
Celularityenters settlement agreement with Helena on May 21, 2026 - marketscreener.com
Celularity Settles With Helena; $500,000 Upfront, 5x$100,000 Payments and $2.5M Note Rights - TradingView
Celularity (NASDAQ: CELU) restructures Helena preferred stock deal with cash and note rights - Stock Titan
Celularity Inc. (CELU) Surges 8% to $0.99 as Stock Tests Key ResistanceEarly Entry Signals - The Legal Advocate
Celularity (CELU) Edges Higher: Navigating Key Resistance at $0.97PCR Divergence - thelegaladvocate.com
Why Is Celularity Inc. (GXGX) Stock Up Today? - Meyka
Why Is Celularity Inc. (GXGXW) Stock Down Today? - Meyka
Celularity Delays Quarterly SEC Filing - TipRanks
Celularity (NASDAQ: CELU) notifies SEC of delayed Q1 2026 10-Q - Stock Titan
NexGel Q1 2026 Earnings Call Transcript - MarketBeat
TradingKey - TradingKey
Sequence execs join NEXGEL (NASDAQ: NXGL) board after $5.5M note deal - Stock Titan
Is Celularity (CELU) a value trap or a value play? (Recovers) 2026-05-08Certified Trade Ideas - Newser
The hidden strength in Celularity (CELU) most investors miss (Underperforming) 2026-05-07Viral Trades - Newser
Celularity regains Nasdaq compliance after delayed filing - MSN
After $5.5M deal backing, Sequence executives take 2 NEXGEL board seats - Stock Titan
NEXGEL Appoints Brian Kieser and Kevin Harris from New - GlobeNewswire
NEXGEL Appoints Ian Blackman CFO Amid Celularity Deal - MyChesCo
Celularity Inc. 2025 Annual 10-K Report: Financials, Debt, Equity, and Major Agreements Overview - Minichart
Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation - Investing News Network
Stocks to watch on Friday after hours: CTLP, CELU, ULH (CTLP:NASDAQ) - Seeking Alpha
Celularity Regains Nasdaq Listing Compliance, Shares Rise - marketscreener.com
Celularity regains Nasdaq compliance after filing annual report By Investing.com - Investing.com Australia
Celularity regains Nasdaq compliance after filing annual report - Investing.com
1.27%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):